UTHR - UNITED THERAPEUTICS Corp
478.16
-6.900 -1.443%
Share volume: 315,914
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$485.06
-6.90
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-01-2024 | 07-31-2024 | 10-30-2024 | 02-26-2025 | 04-30-2025 | 07-30-2025 | 10-29-2025 | 02-25-2026 | |
| Total revenue | 677.700 M | 714.900 M | 748.900 M | 735.900 M | 794.400 M | 798.600 M | 799.500 M | 790.200 M | |
| Cost of revenue | 72.900 M | 77.800 M | 83.100 M | 75.900 M | 92.500 M | 87.600 M | 100.900 M | 103.400 M | |
| Gross profit | 604.800 M | 637.100 M | 665.800 M | 660.000 M | 701.900 M | 711.000 M | 698.600 M | 686.800 M | |
| 5.34% | 4.50% | -0.87% | 6.35% | 1.30% | -1.74% | -1.69% | |||
| Operating expenses | 248.500 M | 317.200 M | 322.700 M | 302.300 M | 319.100 M | 346.500 M | 310.100 M | 330.100 M | |
| Selling general and admin | 144.400 M | 177.600 M | 219.200 M | 168.500 M | 170.100 M | 212.500 M | 182.600 M | 190.600 M | |
| Research and development | 104.100 M | 139.600 M | 103.500 M | 133.800 M | 149.000 M | 134.000 M | 127.500 M | 139.500 M | |
| Total expenses | 321.400 M | 395.000 M | 322.700 M | 302.300 M | 319.100 M | 346.500 M | 310.100 M | 330.100 M | |
| 22.90% | -18.30% | -6.32% | 5.56% | 8.59% | -10.51% | 6.45% | |||
| Operating income | 356.300 M | 319.900 M | 343.100 M | 357.700 M | 382.800 M | 364.500 M | 388.500 M | 356.700 M | |
| Ebit | 356.300 M | 319.900 M | 348.900 M | 355.100 M | 378.500 M | 364.400 M | 394.600 M | 403.900 M | |
| Pretax income | 398.600 M | 355.300 M | 388.600 M | 396.500 M | 423.500 M | 408.400 M | 438.000 M | 444.000 M | |
| -10.86% | 9.37% | 2.03% | 6.81% | -3.57% | 7.25% | 1.37% | |||
| Income tax | 92.000 M | 77.200 M | 79.500 M | 95.200 M | 101.300 M | 98.900 M | 99.300 M | 79.700 M | |
| Net income basic | 306.600 M | 278.100 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| -9.30% | -100.00% | ||||||||
| Net income | 306.600 M | 278.100 M | 309.100 M | 301.300 M | 322.200 M | 309.500 M | 338.700 M | 364.300 M | |
| -9.30% | 11.15% | -2.52% | 6.94% | -3.94% | 9.43% | 7.56% |